Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy

Yan Chaowu1, Zhao Shihua, Ling Jian

  • 1Departments of Radiology, Pathology, and Nuclear Medicine, Cardiovascular Institute and Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Insights

Cardiovascular magnetic resonance (CMR) reveals that late gadolinium enhancement (LGE) in children with hypertrophic cardiomyopathy (HCM) is similar to adults and predicts adverse events, necessitating further research.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Imaging
  • Genetic Heart Diseases

Background:

  • Cardiovascular magnetic resonance (CMR) is crucial for diagnosing and stratifying risk in adult hypertrophic cardiomyopathy (HCM).
  • Limited data exist on CMR findings in pediatric HCM.
  • This study evaluates CMR characteristics in children with idiopathic HCM.

Purpose of the Study:

  • To assess cardiovascular magnetic resonance (CMR) features in children diagnosed with idiopathic hypertrophic cardiomyopathy (HCM).
  • To compare CMR parameters between pediatric HCM patients and healthy children.
  • To investigate the association between CMR findings and adverse clinical outcomes in pediatric HCM.

Main Methods:

  • Cardiovascular magnetic resonance (CMR) was performed on 71 children with idiopathic HCM and compared with 71 healthy controls.
  • Left ventricular (LV) parameters were indexed by body surface area.
  • Late gadolinium enhancement (LGE) prevalence and extent were analyzed.

Main Results:

  • In 71 children with idiopathic HCM, concentric LV hypertrophy was observed in 12.7%, with 2 progressing to end-stage disease.
  • Late gadolinium enhancement (LGE) prevalence was 73%, with an average extent of 10.4% of LV mass.
  • Children with HCM and LGE showed increased LV mass (P=0.025) and LGE extent correlated with adverse events (HR 1.1, P=0.004).

Conclusions:

  • The prevalence and extent of LGE in pediatric HCM are comparable to adult HCM.
  • LGE in children with HCM is associated with a higher risk of adverse events.
  • Larger studies with longer follow-up are needed to confirm these findings in pediatric HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...